Etiology of renal cell carcinoma: Incidence, demographics, and environmental factors

Renal Cell Carcinoma: Clinical Management

Volumn , Issue , 2013, Pages 3-22

  Birkhäuser, Frédéric D ^a   Kroeger, Nils ^a   Pantuck, Allan J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911003080     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-62703-062-5_1     Document Type: Chapter

References (82)

1. World Health Organization (WHO). Globocan 2008. Cancer incidence and mortality worldwide; 2008. http://globocan.iarc.fr/. Accessed Nov 2010.
2. Devesa SS, Silverman DT, McLaughlin JK, Brown CC, Connelly RR, Fraumeni Jr JF. Comparison of the descriptive epidemiology of urinary tract cancers. Cancer Causes Control. 1990;1(2):133-41.
3. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data (1973-2002), National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission; 2005.
4. Mathew A, Devesa SS, Fraumeni Jr JF, Chow WH. Global increases in kidney cancer incidence, 1973-1992. Eur J Cancer Prev. 2002;11(2):171-8.
5. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98(18):1331-4.
6. Chow WH, Linehan WM, Devesa SS. Re: rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2007;99(7):569-70 [author reply 570-1].
7. American Cancer Society. Cancer facts & figures 2010. Atlanta: American Cancer Society; 2010.
8. Sun M, Thuret R, Abdollah F, et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol. 2011;59(1):135-41.
9. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer statistics review, 1975-2007. Bethesda: National Cancer Institute. http://seer.cancer.gov/csr/1975_2007/. Accessed Nov 2010.
10. Chow WH, Devesa SS, Warren JL, Fraumeni Jr JF. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281(17):1628-31.
11. IMV Medical Information Division. CT census database and market summary report. Greenbelt, MD IMV2008.
12. Amis Jr ES, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol. 2007;4(5):272-84.
13. Tada S, Yamagishi J, Kobayashi H, Hata Y, Kobari T. The incidence of simple renal cyst by computed tomography. Clin Radiol. 1983;34(4):437-9.
14. Hara AK, Johnson CD, MacCarty RL, Welch TJ. Incidental extracolonic findings at CT colonography. Radiology. 2000;215(2):353-7.
15. Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 2008;14(5):288-301.
16. World Health Organization (WHO). Fact sheet N311. Obesity and overweight; 2011. http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
17. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
18. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-49.
19. Levi F, Ferlay J, Galeone C, et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int. 2008;101(8):949-58.
20. Levi F, Lucchini F, Negri E, La Vecchia C. Declining mortality from kidney cancer in Europe. Ann Oncol. 2004;15(7):1130-5.
21. Vaishampayan UN, Do H, Hussain M, Schwartz K. Racial disparity in incidence patterns and outcome of kidney cancer. Urology. 2003;62(6):1012-7.
22. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2(5):372-7.
23. Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: A report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US); 2010. Available from: http://0-www.ncbi.nlm.nih.gov.elis.tmu.edu.tw/books/NBK53017/http://0-www.ncbi.nlm.nih.gov.elis.tmu.edu.tw/books/NBK53017/.
24. Thakker DR, Yagi H, Levin W, Wood AW, Conney AH, Jerina DM. Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In: Anders MW, editor. Bioactivation of foreign compounds. New York: Academic; 1985. p. 177-242.
25. Zhu Y, Horikawa Y, Yang H, Wood CG, Habuchi T, Wu X. BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk. J Urol. 2008;179(6):2416-21.
26. Shiao YH, Rice JM, Anderson LM, Diwan BA, Hard GC. von Hippel-Lindau gene mutations in N-nitrosodimethylamine-induced rat renal epithelial tumors. J Natl Cancer Inst. 1998;90(22):1720-3.
27. Swann PF, Kaufman DG, Magee PN, Mace R. Induction of kidney tumours by a single dose of dimethylnitrosamine: dose response and in fluence of diet and benzo(a)pyrene pretreatment. Br J Cancer. 1980;41(2):285-94.
28. Clague J, Shao L, Lin J, et al. Sensitivity to NNKOAc is associated with renal cancer risk. Carcinogenesis. 2009;30(4):706-10.
29. IARC monographs on the evaluation of carcinogenic risks to humans tobacco smoke and involuntary smoking, vol 83. Lyon: World Health Organization International Agency for Research on Cancer; 2004. p. 339-70. Available from: http://apps.who.int/bookorders/anglais/detart1.jsp?sesslan=1&codlan=1&codcol=72&codcch=83.
30. US Department of Health and Human Services. The health consequence of smoking: a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
31. Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114(1):101-8.
32. Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31(1):100-10.
33. Sweeney C, Farrow DC. Differential survival related to smoking among patients with renal cell carcinoma. Epidemiology. 2000;11(3):344-6.
34. Parker A, Lohse C, Cheville J, Leibovich B, Igel T, Blute M. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma. Int J Urol. 2008;15(4):304-8.
35. Hursting SD, Berger NA. Energy balance, host-related factors, and cancer progression. J Clin Oncol. 2010;28(26):4058-65.
36. Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during in flammation: the acute-phase proteins. Protein Pept Lett. 2002;9(3):211-23.
37. Pantuck AJ, Seligson DB, Klatte T, et al. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer. 2007;109(11):2257-67.
38. Hudes G, Carducci M, Tomczak P, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007;356(22):2271-81.
39. Motzer RJ, Escudier B, Oudard S, et al. Phase 3 trial of everolimus for metastatic renal cell carcinoma: final results and analysis of prognostic factors. Cancer. 2010;116(18):4256-65.
40. Masur K, Vetter C, Hinz A, et al. Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation. Br J Cancer. 2011;104(2):345-52.
41. Mussig K, Haring HU. Insulin signal transduction in normal cells and its role in carcinogenesis. Exp Clin Endocrinol Diabetes. 2010;118(6):356-9.
42. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8(12): 915-28.
43. Takahashi K, Suzuki K. Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells. Int J Cancer. 1993;55(3):453-8.
44. Klatte T, Said JW, de Martino M, et al. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J Urol. 2009;181(4):1558-64 [discussion 1563-4].
45. Noon AP, Vlatkovic N, Polanski R, et al. p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets? Cancer. 2010;116(4):780-90.
46. Tilg H, Moschen AR. Evolution of in flammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836-46.
47. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis. 2010;31(1):83-9.
48. Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer. 2004;108(1):115-21.
49. Gonzalez CA, Riboli E. Diet and cancer prevention: contributions from the european prospective investigation into cancer and nutrition (EPIC) study. Eur J Cancer. 2010;46(14):2555-62.
50. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9 Suppl 4:228S-33.
51. Sawada N, Inoue M, Sasazuki S, et al. Body mass index and subsequent risk of kidney cancer: a prospective cohort study in Japan. Ann Epidemiol. 2010;20(6):466-72.
52. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2006;118(3):728-38.
53. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4(8):579-91.
54. Lowrance WT, Thompson RH, Yee DS, Kaag M, Donat SM, Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int. 2010;105(1):16-20.
55. Lee JE, Mannisto S, Spiegelman D, et al. Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev. 2009;18(6): 1730-9.
56. Lindblad P, Wolk A, Bergstrom R, Adami HO. Diet and risk of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 1997;6(4):215-23.
57. Weikert S, Boeing H, Pischon T, et al. Fruits and vegetables and renal cell carcinoma: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2006;118(12): 3133-9.
58. Allen NE, Roddam AW, Sieri S, et al. A prospective analysis of the association between macronutrient intake and renal cell carcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer. 2009;125(4):982-7.
59. Lee JE, Spiegelman D, Hunter DJ, et al. Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst. 2008;100(23):1695-706.
60. Mellemgaard A, McLaughlin JK, Overvad K, Olsen JH. Dietary risk factors for renal cell carcinoma in Denmark. Eur J Cancer. 1996;32A(4):673-82.
61. Lee JE, Giovannucci E, Smith-Warner SA, Spiegelman D, Willett WC, Curhan GC. Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2445-52.
62. Hu J, Mao Y, White K. Diet and vitamin or mineral supplements and risk of renal cell carcinoma in Canada. Cancer Causes Control. 2003;14(8):705-14.
63. Wolk A, Gridley G, Niwa S, et al. International renal cell cancer study. VII. Role of diet. Int J Cancer. 1996;65(1):67-73.
64. Wolk A, Larsson SC, Johansson JE, Ekman P. Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA. 2006;296(11):1371-6.
65. Lee JE, Hunter DJ, Spiegelman D, et al. Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst. 2007;99(10): 801-10.
66. Chiu BC, Gapstur SM, Chow WH, Kirby KA, Lynch CF, Cantor KP. Body mass index, physical activity, and risk of renal cell carcinoma. Int J Obes (Lond). 2006;30(6):940-7.
67. Moore SC, Chow WH, Schatzkin A, et al. Physical activity during adulthood and adolescence in relation to renal cell cancer. Am J Epidemiol. 2008;168(2):149-57.
68. Bergstrom A, Terry P, Lindblad P, et al. Physical activity and risk of renal cell cancer. Int J Cancer. 2001;92(1):155-7.
69. Waalkes S, Merseburger AS, Kramer MW, et al. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer. Cancer Causes Control. 2010;21(11):1905-10.
70. Haferkamp A, Pritsch M, Bedke J, et al. The in fluence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy. BJU Int. 2008;101(10):1243-6.
71. Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma. Urology. 2006;68(4):741-6.
72. Andreotti G, Boffetta P, Rosenberg PS, et al. Variants in blood pressure genes and the risk of renal cell carcinoma. Carcinogenesis. 2010;31(4):614-20.
73. Sane DC, Anton L, Brosnihan KB. Angiogenic growth factors and hypertension. Angiogenesis. 2004;7(3): 193-201.
74. Chow WH, Gridley G, Fraumeni Jr JF, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343(18):1305-11.
75. Flaherty KT, Fuchs CS, Colditz GA, et al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control. 2005;16(9): 1099-106.
76. Weikert S, Boeing H, Pischon T, et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167(4):438-46.
77. Vatten LJ, Trichopoulos D, Holmen J, Nilsen TI. Blood pressure and renal cancer risk: the HUNT Study in Norway. Br J Cancer. 2007;97(1):112-4.
78. Weikert S, Ljungberg B. Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention. World J Urol. 2010;28(3):247-52.
79. Corrao G, Scotti L, Bagnardi V, Sega R. Hypertension, antihypertensive therapy and renal-cell cancer: a meta-analysis. Curr Drug Saf. 2007;2(2):125-33.
80. Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol. 1999;149(6):521-30.
81. McLaughlin JK, Chow WH, Mandel JS, et al. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer. 1995;63(2):216-21.
82. Choi MY, Jee SH, Sull JW, Nam CM. The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int. 2005;67(2):647-52.